Teladoc Health (NYSE:TDOC) Shares Gap Up – Should You Buy?

Teladoc Health, Inc. (NYSE:TDOC)’s share price gapped up before the market opened on Monday . The stock had previously closed at $10.62, but opened at $11.14. Teladoc Health shares last traded at $11.34, with a volume of 305,390 shares traded.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the stock. TD Cowen dropped their price target on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research report on Thursday, October 31st. Canaccord Genuity Group cut their target price on shares of Teladoc Health from $25.00 to $17.00 and set a “buy” rating for the company in a research report on Thursday, August 1st. The Goldman Sachs Group started coverage on Teladoc Health in a research report on Friday, November 15th. They issued a “buy” rating and a $14.00 price target on the stock. Stifel Nicolaus decreased their target price on Teladoc Health from $16.00 to $9.00 and set a “hold” rating for the company in a research note on Thursday, August 1st. Finally, Piper Sandler dropped their price target on Teladoc Health from $25.00 to $10.00 and set an “overweight” rating on the stock in a research report on Tuesday, August 6th. Fourteen equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $12.08.

Teladoc Health Trading Up 14.5 %

The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The firm has a market cap of $2.09 billion, a price-to-earnings ratio of -2.01 and a beta of 0.90. The company’s 50-day moving average is $9.10 and its 200-day moving average is $9.25.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.10. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.51 million during the quarter, compared to analyst estimates of $630.50 million. On average, research analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Insider Activity at Teladoc Health

In other Teladoc Health news, COO Michael Willem Waters sold 4,218 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total transaction of $30,200.88. Following the transaction, the chief operating officer now owns 78,309 shares in the company, valued at approximately $560,692.44. This trade represents a 5.11 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Thomas Mckinley purchased 4,000 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The stock was purchased at an average price of $7.69 per share, for a total transaction of $30,760.00. Following the completion of the transaction, the director now directly owns 39,077 shares in the company, valued at $300,502.13. This trade represents a 11.40 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have sold a total of 20,051 shares of company stock worth $143,565 over the last 90 days. Insiders own 0.95% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

Several large investors have recently bought and sold shares of the company. Rubric Capital Management LP acquired a new stake in shares of Teladoc Health during the second quarter worth about $45,267,000. Point72 Asset Management L.P. raised its holdings in Teladoc Health by 221.9% during the 2nd quarter. Point72 Asset Management L.P. now owns 5,303,123 shares of the health services provider’s stock worth $51,865,000 after buying an additional 3,655,436 shares during the period. Clearline Capital LP raised its holdings in Teladoc Health by 395.6% during the 2nd quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider’s stock worth $42,682,000 after buying an additional 3,483,665 shares during the period. Assenagon Asset Management S.A. bought a new position in Teladoc Health in the third quarter valued at approximately $15,801,000. Finally, Maple Rock Capital Partners Inc. acquired a new position in shares of Teladoc Health in the third quarter valued at approximately $11,291,000. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.